Purchase Order N6311623P0545
Award Date
6/29/23
Potential Completion Date
7/30/23
Potential Value
$8K
Federal Agency
Bureau of Medicine and Surgery
Ultimate Awardee
Not listed
NAICS Category
611699 - All Other Miscellaneous Schools and Instruction
PSC Category
U004 - Education/Training- Scientific/Management
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Office of Naval Research (ONR), a defense agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $51,447 firm fixed-price purchase order is for the supply of chemicals and consumables required for the operation of Oxford Nanopore's proprietary instruments. The contract has an ultimate completion date of October 31, 2024 and does not have a set-aside designation. Oxford Nanopore Technologies is a...
This federal contract award, valued at $17,732.00, was made by the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of various Oxford Nanopore sequencing products, including MinION flow cells, VolTRAX sequencing kits, Flongle flow kits, and flow cell wash kits. These products are to be used with the Oxford Nanopore MinION sequencing device...
The U.S. Defense agency, the Bureau of Medicine and Surgery, awarded a $80,045.00 firm-fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract, identified as N3239824P0044, is for the delivery of P2 INTEGRATED CAPEX and has an ultimate completion date of September 29, 2025. Oxford Nanopore Technologies provides next-generation genomic sequencing equipment, consumables, and associated services to various U.S....
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit organization, to provide MINION-2 SEQUENCERS. The contract has a ceiling value of $38,062 and a completion date of October 9, 2020. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
This is a firm fixed-price purchase order contract awarded by the Pacific West Area of the U.S. government to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $10,000.00 contract, which has a set-aside for small businesses, is for the provision of training on nanopore sequencing with the GridION Mk1 system. The ultimate completion date for this contract is July 23, 2024. Oxford Nanopore Technologies Inc. is a leading provider of innovative sequencing...
This contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for a software license and device warranty. The $13,500.00 firm fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health (NIH). The contract will provide Oxford Nanopore's next-generation genomic sequencing products and services to support various research initiatives through February 1, 2026. Oxford Nanopore has...